Lars Fruergaard Jørgensen might not be a household name, but his company’s drug Ozempic is. And its success has thrust him — ...

Lars Fruergaard Jørgensen is a CEO who didn't want to be CEO but under his tenure Novo Nordisk, which makes Ozempic, has ...

Investors are scrambling to adjust, after the telehealth specialist Hims & Hers said it would stop selling an alternative to ...

Accordingly, shareholders can choose between participating in person at Bella Center, Center Boulevard 5, DK-2300 Copenhagen ...

American demand for weight-loss drugs is supercharging Denmark’s economy and transforming a small Danish community into an ...

A new survey has shown which companies in Denmark are trusted the most and least. Novo Nordisk is at the top, followed by ...

Pharmaceutical giant Novo Nordisk (NYSE: NVO) released its fourth-quarter and full-year earnings report on Feb. 5. The ...

Novo Nordisk thrives despite competition and explore its breakthrough amycretin study. Read here to know why we rate NVO ...

Danish start-up Fuse Vectors has received $5.2 million in preseed financing to further develop their gene therapy technology.

For decades, scientists believed that infections were determined solely by viruses and bacteria. But Professor Jean-Laurent ...

Having examined the options trading patterns of Novo Nordisk, our attention now turns directly to the company. This shift ...

Novo Nordisk shares jumped as much as 4% in Denmark. Hims will stop offering compounded semaglutide after the first quarter, the company said late Monday. The product is a version of the active ...